A report in the New York Times claims that the risk calculator released last week by the AHA is flawed. 

A leading cardiologist has called for the calculator to be withdrawn until the flaws are sorted out.

In addition two Harvard Medical School profs have independently claimed that the calculator overstates risk by 75 to 150%. They claim that this is because the base data that is used for calculations is out of date and thus over predicts risk.

It makes me wonder why such a mistake happens, especially when the Statin Sales Engine has so much to gain when the pool of treatable candidates gets bigger and bigger!

Click to read the NY Times article